What is ARWR's current stock price?

As of now, ARWR is trading at $65.28, with a daily change of +2.26%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

ARWR Stock Analysis & IQ Rating | Arrowhead Pharmaceuticals

ARWR

Arrowhead Pharmaceuticals

$65.28

+$1.44 | +2.26%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$76.76

MKT CAP

$8.96B

52W Low

$9.57

VOL

$1.41M

P/E Ratio

N/A

AVG VOL

$2.89M

RSI

51.96

TREND

Uptrend

ARWR Stock IQ

Login to see Arrowhead Pharmaceuticals (ARWR) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

ARWR Target Price

Login to display

Strengths

ARWR Rewards

Upgraded on attractively valued

ARWR Rewards

Earnings are forecast to grow

ARWR Rewards

Outperform the market

ARWR Price Performance

$68.16 (-4.23%)

$37.35 (+74.78%)

$21.18 (+208.22%)

$19.68 (+231.71%)

1year

6month

3month

1month

ARWR Analysts Opinion

ARWR overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

ARWR Analysts Opinion

ARWR Analysts opinion is negative and it remained unchanged from the past 3 months

ARWR Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

67%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

50%

100%

ARWR Street Sentiment

ARWR Street Sentiment is bullish and have positive views on the near-term outlook

ARWR Risk Level

ARWR has Extreme risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

High volatilty

Extreme

LOW

HIGH

ARWR Performance Sentiment

Sentiments overview associated with ARWR events and the stock performance.

67%

17%

Positive

Negative

8 out of 12
events present

2 out of 12
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$63.84

Resistance
Price

$55.40

Current Price Range

$70.81

Show methods +

Linked to ARWR

IQ

Close Price

Change

NVS

4.80

143.58

-0.53%

SNY

2.80

45.74

-1.82%

WVE

3.93

13.82

+1.25%

EBS

3.40

11.10

+1.00%

Recently Viewed

Close Price

Change

ARWR

Arrowhead Pharmaceuticals

65.28

+2.26%

CLDX

Celldex Therapeutics

25.14

-1.99%

TPR

Tapestry

129.16

-1.17%

DOCS

Doximity

41.10

-0.39%

CADE

Cadence Bancorporation

44.50

-0.02%

ARWR Latest Analysis +

Arrowhead Pharmaceuticals (ARWR) Price Target Increased by 23.01% to 77.60. The average one-year price target for Arrowhead Pharmaceuticals (NasdaqGS:ARWR) has been revised to $77.60 / share. This is an increase of 23.01% from the prior estimate of $63.08 dated December 18 2025. The price target is an average of many targets provided

Wed Jan 14, 2026

$65.91 | +0.56%

Potential

Arrowhead Pharmaceuticals Inc. (ARWR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript.

Mon Jan 12, 2026

$65.93 | +2.12%

Activity

Arrowhead Pharmaceuticals prices upsize convertible notes offering to $625M and stock offering at $64.50.

Thu Jan 8, 2026

$65.00 | -1.05%

Activity

ARWR: Encouraging Early Data for Obesity Programs. By Business UpdateEncouraging Early Data for Obesity ProgramsOn January 6 2026 Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) announced preliminary results for the companys investigational treatments for obesity ARO-INHBE and ARO-ALK7. The company also held a webinar to discuss the results. The slides and the webinar can be accessed here. The data showed that ARO-INHBE both as a monotherapy and in combination with tirzepatide led to reductions in

Wed Jan 7, 2026

$65.69 | -7.23%

Activity

Arrowhead gains approval of Redemplo in China for high triglycerides.

Wed Jan 7, 2026

$65.69 | -7.23%

Activity

Arrowhead Obesity Drugs Show Significant Fat Loss In Early Human Trials. ) on Tuesday shared interim results from two Phase 1/2a trials of ARO-INHBE and ARO-ALK7 the company’.s investigational RNA interference (RNAi) therapeutics for obesity.Preliminary results showed meaningful reductions in multiple key measures including visceral fat .Unlike current GLP-1 drugs (like Wegovy or Zepbound) that primarily reduce appetite these candidates aim to change how the body stores and burns fat by sil

Tue Jan 6, 2026

$70.81 | +10.85%

Activity

Arrowhead gains as obesity therapy doubles wight loss with Lillys Zepbound.

Tue Jan 6, 2026

$70.81 | +10.85%

Momentum

Noteworthy Monday Option Activity: ARWR MS MPC. Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Arrowhead Pharmaceuticals Inc (Symbol: ARWR) where a total of 11698 contracts have traded so far representing approximately 1.2 million underlying shares. That amount

Mon Jan 5, 2026

$63.88 | -5.77%

Momentum

Arrowhead Pharma Unusual Options Activity For January 05. Financial giants have made a conspicuous bearish move on Arrowhead Pharma. Our analysis of options history for Arrowhead Pharma (NASDAQ:) revealed 8 unusual trades.Delving into the details we found 37% of traders were ish while 50% showed bearish tendencies. Out of all the trades we spotted 5 were puts with a value of $175050 and 3 were calls valued at $257150.After evaluating the trading volumes and Open Interest it'.s evident that t

Mon Jan 5, 2026

$63.88 | -5.77%

Momentum

FAQ About ARWR Stock Insights

What is ARWR current stock price?

What are ARWR stock strengths?

What is ARWR Risk Level?

What is ARWR market cap and volume?

What is ARWR current Stock IQ?

Should I buy ARWR stock right now?

Is ARWR a Strong Buy right now?

What does a 'Strong Buy' rating mean for ARWR?

What does a 'Strong Sell' rating mean for ARWR?

What factors influence ARWR's Stock IQ?

Explore our ARWR Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored ARWR Stock Strategies
Effective Risk Management

FIND US ON

Receive our ARWR Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

ARWR

Arrowhead Pharmaceuticals

Set Alerts

Current Price

$65.28

+$1.44 | +2.26%

52W High

$76.76

MKT CAP

$8.96B

52W Low

$9.57

VOL

$1.41M

P/E Ratio

N/A

AVG VOL

$2.89M

RSI

51.96

TREND

Uptrend

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Stock Insights

Strengths

ARWR Rewards

Upgraded on attractively valued

ARWR Rewards

Earnings are forecast to grow

ARWR Rewards

Outperform the market

Linked to ARWR

Symbol

IQ

Close

Change

NVS

4.80

143.58

-0.53%

SNY

2.80

45.74

-1.82%

WVE

3.93

13.82

+1.25%

EBS

3.40

11.10

+1.00%

ARWR Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

67%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

50%

100%

ARWR Street Sentiment

ARWR Street Sentiment is bullish and have positive views on the near-term outlook

ARWR Risk Level

ARWR has Extreme risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

High volatilty

Extreme

LOW

HIGH

ARWR Performance Sentiment

Sentiments overview associated with ARWR events and the stock performance.

67%

17%

Positive

Negative

8 out of 12
events present

2 out of 12
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$63.84

Resistance
Price

$55.40

Current Price Range

$70.81

Show methods +

Latest Analysts Recommendations

Date

Action

Rating

Firm

Jan 11, 2026

Reiterate

Overweight

Piper Sandler

Dec 12, 2025

Reiterate

Outperform

RBC

Dec 10, 2025

Reiterate

Buy

B of A Securities

Dec 02, 2025

Reiterate

Buy

HC Wainwright & Co.

Dec 02, 2025

Reiterate

Buy

B of A Securities

ARWR Stock IQ

Login to unlock Arrowhead Pharmaceuticals (ARWR) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

ARWR Latest Analysis

Arrowhead Pharmaceuticals (ARWR) Price Target Increased by 23.01% to 77.60. The average one-year price target for Arrowhead Pharmaceuticals (NasdaqGS:ARWR) has been revised to $77.60 / share. This is an increase of 23.01% from the prior estimate of $63.08 dated December 18 2025. The price target is an average of many targets provided

Wed Jan 14, 2026

$65.91 | +0.56%

Potential

Arrowhead Pharmaceuticals Inc. (ARWR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript.

Mon Jan 12, 2026

$65.93 | +2.12%

Activity

Arrowhead Pharmaceuticals prices upsize convertible notes offering to $625M and stock offering at $64.50.

Thu Jan 8, 2026

$65.00 | -1.05%

Activity

ARWR: Encouraging Early Data for Obesity Programs. By Business UpdateEncouraging Early Data for Obesity ProgramsOn January 6 2026 Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) announced preliminary results for the companys investigational treatments for obesity ARO-INHBE and ARO-ALK7. The company also held a webinar to discuss the results. The slides and the webinar can be accessed here. The data showed that ARO-INHBE both as a monotherapy and in combination with tirzepatide led to reductions in

Wed Jan 7, 2026

$65.69 | -7.23%

Activity

Arrowhead gains approval of Redemplo in China for high triglycerides.

Wed Jan 7, 2026

$65.69 | -7.23%

Activity

Arrowhead Obesity Drugs Show Significant Fat Loss In Early Human Trials. ) on Tuesday shared interim results from two Phase 1/2a trials of ARO-INHBE and ARO-ALK7 the company’.s investigational RNA interference (RNAi) therapeutics for obesity.Preliminary results showed meaningful reductions in multiple key measures including visceral fat .Unlike current GLP-1 drugs (like Wegovy or Zepbound) that primarily reduce appetite these candidates aim to change how the body stores and burns fat by sil

Tue Jan 6, 2026

$70.81 | +10.85%

Activity

Arrowhead gains as obesity therapy doubles wight loss with Lillys Zepbound.

Tue Jan 6, 2026

$70.81 | +10.85%

Momentum

Noteworthy Monday Option Activity: ARWR MS MPC. Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Arrowhead Pharmaceuticals Inc (Symbol: ARWR) where a total of 11698 contracts have traded so far representing approximately 1.2 million underlying shares. That amount

Mon Jan 5, 2026

$63.88 | -5.77%

Momentum

Arrowhead Pharma Unusual Options Activity For January 05. Financial giants have made a conspicuous bearish move on Arrowhead Pharma. Our analysis of options history for Arrowhead Pharma (NASDAQ:) revealed 8 unusual trades.Delving into the details we found 37% of traders were ish while 50% showed bearish tendencies. Out of all the trades we spotted 5 were puts with a value of $175050 and 3 were calls valued at $257150.After evaluating the trading volumes and Open Interest it'.s evident that t

Mon Jan 5, 2026

$63.88 | -5.77%

Momentum

Discover ARWR Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of ARWR. We're here to help you make informed investment decisions today.

FIND US ON

Receive our ARWR Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

ARWR Stock trends

ARWR Stock performance

ARWR Stock analysis

ARWR investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing ARWR

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing ARWR

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

ARWR Stock Analysis & IQ Rating | Arrowhead Pharmaceuticals

ARWR Stock IQ

ARWR Target Price

ARWR Analysts Opinion

ARWR Street Sentiment

ARWR Risk Level

ARWR Performance Sentiment

Technical Price Levels

Explore our ARWR Stock insights

Receive our ARWR Daily Alerts

ARWR Street Sentiment

ARWR Risk Level

Technical Price Levels

Latest Analysts Recommendations

Discover ARWR Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of ARWR. We're here to help you make informed investment decisions today.

Receive our ARWR Daily Alerts

ARWR Alerts